C48.1
Malignant neoplasm of specified parts of peritoneum
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of cul-de-sac
- Malignant neoplasm of mesentery
- Malignant neoplasm of mesocolon
- Malignant neoplasm of omentum
- Malignant neoplasm of parietal peritoneum
- Malignant neoplasm of pelvic peritoneum
Medical Intelligence & Overview
ICD-10 code C48.1 refers to malignant tumors located in specific parts of the peritoneum, including areas such as the cul-de-sac, mesentery, mesocolon, omentum, and the parietal and pelvic peritoneum. These are types of cancers that develop in the lining of the abdominal cavity, known as the peritoneum. Recognizing the location and nature of these tumors is important for diagnosis and treatment planning, although medical advice should always be sought from healthcare professionals.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to uncontrolled cell growth within the peritoneal lining. Chronic inflammatory conditions affecting the abdominal cavity. History of previous cancers, especially ovarian or gastrointestinal cancers. Environmental factors such as exposure to carcinogens or toxins. Family history of peritoneal or other related cancers.
Key Symptoms: Abdominal pain or discomfort Bloating or swelling in the abdomen Unexplained weight loss Changes in bowel habits, such as constipation or diarrhea Feeling of fullness or early satiety Ascites, which is fluid accumulation in the abdomen General fatigue and weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosing tumors in these specific parts of the peritoneum involves a combination of medical imaging and laboratory tests. Common methods include:
Treatment Protocols: Management of malignant neoplasms in these areas typically involves multidisciplinary approaches, including:
Clinical Advice & FAQs
Billing Guidance
Is C48.1 a billable ICD-10 code?
Yes, C48.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C48.1?
Clinical documentation must specify the nature of Malignant neoplasm of specified parts of peritoneum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference